SGHT News and Press, Sight Sciences Inc. From 11/12/21

Image source: The Motley Fool. Sight Sciences, Inc. (NASDAQ: SGHT) Q3 2021 Earnings Call Nov 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Sight Sciences, Inc. (SGHT) Q3 2021 Earnings Call Transcript

Sight Sciences (NASDAQ:SGHT): Q3 GAAP EPS of -$0.43 misses by $0.07. Revenue of $13.1M (+51.4% Y/Y) beats by $1.03M. Press Release For further details see: Sight Sciences EPS misses by $0.07, beats on revenue

MENLO PARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter ende...

MENLO PARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced that the Food and Drug Admin...

MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT) today announced it will report financial results for the quarter ended September 30, 2021 after the market close on Wednesday, November 10, 2021. The company’s management will discuss the r...

On Thursday, Sight Sciences Inc. ( NASDAQ:SGHT ) shares rallied more than 12% after reporting positive TearCare data . SGHT is exploring how TearCare could be used for localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction. ...

MENLO PARK, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world's most prevalent eye diseases, today announced publication in the journal Cornea of posi...

MENLO PARK, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ: SGHT) today announced that it filed a lawsuit in the United States District Court in Delaware against Ivantis, Inc. for infringement of U.S. Patent Numbers 8,287,482, 9,370,443, 9,486,361, and 10,314,742. T...

The following slide deck was published by Sight Sciences, Inc. in conjunction with this event. For further details see: Sight Sciences (SGHT) Investor Presentation - Slideshow

Of your five senses, eye sight ranks up there as most important, and essential. Unfortunately, for some of us, we don’t have the best vision. In fact, some of us deal with what’s known as Aniseikonia, or as noted by Clinical and Experimental Optometry “is a difference i...